Schedule 13G ownership disclosure

NASUS PHARMA LTD

Ordinary Shares, no par value · CUSIP: M7071P109

Event date: 2025-08-14

Filing-level shares
575,129
Percent of class
6.35%
  • Capital Point Ltd.

    Shares: 575,129 · Class: 6.35%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-25-003007
Form type
SCHEDULE 13G
Filer
Capital Point Ltd.
CIK
CIK 1634113
Filed
Aug 20, 2025
Reporting period
Aug 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub